itraconazole has been researched along with Influenza, Human in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Samaddar, A; Sharma, A; Shrimali, T | 1 |
| Goretzko, J; Ludwig, S; Pleschka, S; Rescher, U; Schloer, S | 1 |
| Hasejima, N; Kadoyama, C; Kobayashi, H; Takezawa, S; Yamato, K | 1 |
| Adachi, M; Andou, K; Hirose, T; Horichi, N; Hosaka, T; Ishida, H; Kusumoto, S; Nakashima, M; Ohnishi, T; Okuda, K; Shirai, K; Sugiyama, H; Yamaoka, T | 1 |
2 review(s) available for itraconazole and Influenza, Human
| Article | Year |
|---|---|
Pulmonary infection due to Acrophialophora fusispora in a patient with underlying mixed connective tissue disease and chronic pulmonary aspergillosis: A case report and review of literature.
Topics: Antifungal Agents; Ascomycota; Chronic Disease; Coinfection; Humans; Immunocompromised Host; Influenza A Virus, H1N1 Subtype; Influenza, Human; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Mixed Connective Tissue Disease; Opportunistic Infections; Pulmonary Aspergillosis | 2020 |
Invasive pulmonary aspergillosis associated with influenza B.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Female; Humans; Immunocompetence; Influenza B virus; Influenza, Human; Itraconazole; Lung Diseases, Fungal; Middle Aged | 2005 |
2 other study(ies) available for itraconazole and Influenza, Human
| Article | Year |
|---|---|
Combinatory Treatment with Oseltamivir and Itraconazole Targeting Both Virus and Host Factors in Influenza A Virus Infection.
Topics: Antiviral Agents; Cell Line; Drug Synergism; Drug Therapy, Combination; Host-Pathogen Interactions; Humans; Influenza A virus; Influenza, Human; Itraconazole; Oseltamivir | 2020 |
[Two cases of successfully treated invasive pulmonary aspergillosis following influenza virus infection].
Topics: Aged; Alphainfluenzavirus; Amphotericin B; Antifungal Agents; Aspergillosis; Betainfluenzavirus; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Female; Humans; Influenza, Human; Itraconazole; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Peptides, Cyclic | 2007 |